MX9700007A - Anticuerpos que fijan las proteinas del intestino de los insectos y su uso. - Google Patents
Anticuerpos que fijan las proteinas del intestino de los insectos y su uso.Info
- Publication number
- MX9700007A MX9700007A MX9700007A MX9700007A MX9700007A MX 9700007 A MX9700007 A MX 9700007A MX 9700007 A MX9700007 A MX 9700007A MX 9700007 A MX9700007 A MX 9700007A MX 9700007 A MX9700007 A MX 9700007A
- Authority
- MX
- Mexico
- Prior art keywords
- bind
- antibodies
- insect
- insect gut
- proteins
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 241000238631 Hexapoda Species 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 239000012528 membrane Substances 0.000 abstract 2
- 210000000110 microvilli Anatomy 0.000 abstract 2
- 241000607479 Yersinia pestis Species 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 210000001589 microsome Anatomy 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/50—Isolated enzymes; Isolated proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6843—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6845—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
- C07K14/325—Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Pest Control & Pesticides (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Physics & Mathematics (AREA)
- Agronomy & Crop Science (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Insects & Arthropods (AREA)
- Environmental Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Se proporcionan anticuerpos monoclonales o fragmentos de los mismos que se fijan a las vesículas de la membrana del borde piloso del intestino de los insectos y el gen o genes que codifican estas proteínas. Los anticuerpos monoclonales se fijan al intestino de un insecto que constituye el objetivo, pero no se fijan las membranas del borde piloso de los mamíferos o a los microsomas de las plantas. Los anticuerpos y los genes que los codifican son utiles para la construccion de toxinas híbridas para el control de plagas de insectos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26764194A | 1994-06-28 | 1994-06-28 | |
PCT/IB1995/000497 WO1996000783A1 (en) | 1994-06-28 | 1995-06-20 | Antibodies which bind to insect gut proteins and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9700007A true MX9700007A (es) | 1997-04-30 |
Family
ID=23019624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9700007A MX9700007A (es) | 1994-06-28 | 1995-06-20 | Anticuerpos que fijan las proteinas del intestino de los insectos y su uso. |
Country Status (16)
Country | Link |
---|---|
US (2) | US5686600A (es) |
EP (1) | EP0804579A1 (es) |
JP (1) | JPH11505401A (es) |
CN (1) | CN1151759A (es) |
AU (1) | AU696661B2 (es) |
BG (1) | BG101171A (es) |
BR (1) | BR9508154A (es) |
CA (1) | CA2193859A1 (es) |
CZ (1) | CZ382196A3 (es) |
EE (1) | EE9600192A (es) |
HU (1) | HUT76089A (es) |
MX (1) | MX9700007A (es) |
NZ (1) | NZ287124A (es) |
PL (1) | PL318164A1 (es) |
SK (1) | SK166996A3 (es) |
WO (1) | WO1996000783A1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2246242A1 (en) * | 1996-02-08 | 1997-08-14 | Institut Fur Pflanzengenetik Und Kulturpflanzenforschung | Cassettes for the expression of storable proteins in plants |
AU727218B2 (en) | 1997-04-03 | 2000-12-07 | Syngenta Participations Ag | Plant pest control |
US7011835B1 (en) | 1997-07-10 | 2006-03-14 | Research Development Foundation | Targeted destruction of pests |
US6013510A (en) * | 1997-09-25 | 2000-01-11 | Becton, Dickinson And Company | Identification of a DNA region potentially useful for the detection of Mycobacterium kansasii |
US7250494B2 (en) * | 1998-06-15 | 2007-07-31 | Biosynexus Incorporated | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
US6187558B1 (en) | 1998-06-24 | 2001-02-13 | Boyce Thompson Institute For Plant Research, Inc. | Invertebrate intestinal mucin cDNA and related products and methods |
WO1999067373A2 (en) * | 1998-06-24 | 1999-12-29 | Boyce Thompson Institute For Plant Research, Inc. | Invertebrate intestinal mucins, cdnas, antibodies and their use |
ES2246093T3 (es) * | 1998-10-16 | 2006-02-01 | Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. | Patogenicida molecular que induce una resistencia a la enfermedad en las plantas. |
AU2001236806A1 (en) * | 2000-02-10 | 2001-08-20 | Research Development Foundation | Targeted destruction of pests |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US7465790B2 (en) * | 2000-10-09 | 2008-12-16 | Isis Innovation, Inc. | Therapeutic antibodies |
AU2001293995B2 (en) | 2000-10-09 | 2005-10-13 | Cytomx Therapeutics, Inc. | Therapeutic antibodies |
US7030156B2 (en) | 2001-03-05 | 2006-04-18 | University Of Florida Research Foundation, Inc | Devices and methods for eliminating termite colonies |
US6716421B2 (en) | 2001-03-05 | 2004-04-06 | University Of Florida Research Foundation, Inc. | Devices and methods for eliminating termite colonies |
US6969512B2 (en) | 2001-03-05 | 2005-11-29 | The University Of Florida Research Foundation, Inc. | Devices and methods for eliminating termite colonies |
US20050176928A1 (en) * | 2001-03-23 | 2005-08-11 | Syngenta Participations Ag | Insect nuclear receptor genes and uses thereof |
GB0119274D0 (en) * | 2001-08-08 | 2001-10-03 | Univ Durham | Fusion proteins for insect control |
US20040052779A1 (en) * | 2001-12-21 | 2004-03-18 | Stinson Jeffrey R. | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
US20040063912A1 (en) * | 2002-03-15 | 2004-04-01 | The Brigham And Women's Hospital, Inc. | Central airway administration for systemic delivery of therapeutics |
US20040016004A1 (en) * | 2002-04-01 | 2004-01-22 | Raitano Arthur B. | Nucleic acid and corresponding protein entitled 238P1B2 useful in treatment and detection of cancer |
US7531522B2 (en) | 2002-04-22 | 2009-05-12 | Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. | Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
US8025873B2 (en) | 2002-06-20 | 2011-09-27 | Paladin Labs, Inc. | Chimeric antigens for eliciting an immune response |
US8029803B2 (en) * | 2002-06-20 | 2011-10-04 | Paladin Labs, Inc. | Chimeric antigens for eliciting an immune response |
US8007805B2 (en) * | 2003-08-08 | 2011-08-30 | Paladin Labs, Inc. | Chimeric antigens for breaking host tolerance to foreign antigens |
KR20070008714A (ko) | 2004-04-30 | 2007-01-17 | 오르버스네이치 메디칼 인코포레이티드 | 유전적으로-변형된 세포 포획용 코팅을 갖는 의료 장치 및이의 사용 방법 |
CN101300355A (zh) * | 2005-10-13 | 2008-11-05 | 威瑞克斯医药公司 | 包含丙型肝炎病毒多肽和用于引起免疫应答的Fc片段的嵌合抗原 |
US8415271B2 (en) * | 2007-04-21 | 2013-04-09 | Uxmal S.A. | Biofertilizer formulation |
WO2008156763A2 (en) * | 2007-06-15 | 2008-12-24 | The Board Of Trustees Of The Leland Stanford Junior University | Human neutralizing monoclonal antibodies to h5n1 influenza a virus |
EP2215247B1 (en) * | 2007-11-13 | 2014-09-24 | The Scripps Research Institute | Production of cytotoxic antibody-toxin fusion in eukaryotic algae |
CN102482347B (zh) | 2009-01-12 | 2017-04-26 | 希托马克斯医疗有限责任公司 | 修饰抗体组合物及其制备和使用方法 |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
EP3415010A1 (en) * | 2017-06-13 | 2018-12-19 | Agrosavfe Nv | Insect-controlling polypeptides and methods |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5290914A (en) * | 1988-04-28 | 1994-03-01 | Mycogen Corporation | Hybrid diphtheria-B.t. pesticidal toxins |
US5196320A (en) * | 1989-09-20 | 1993-03-23 | Abbott Biotech, Inc. | Method of producing engineered binding proteins |
US5202422A (en) * | 1989-10-27 | 1993-04-13 | The Scripps Research Institute | Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins and method of their use |
EP0438312A3 (en) * | 1990-01-19 | 1992-07-01 | Merck & Co. Inc. | Recombinant human anti-cd18 antibodies |
US5143905A (en) * | 1990-05-03 | 1992-09-01 | The Regents Of The University Of California | Method and means for extending the host range of insecticidal proteins |
US5665595A (en) * | 1991-06-07 | 1997-09-09 | Dowelanco | Immunoglobulins against insect tissue |
ES2082429T3 (es) * | 1991-07-25 | 1996-03-16 | Ciba Geigy Ag | Metodo de deteccion inmunologico. |
-
1995
- 1995-05-16 US US08/442,542 patent/US5686600A/en not_active Expired - Fee Related
- 1995-06-20 EE EE9600192A patent/EE9600192A/xx unknown
- 1995-06-20 CZ CZ963821A patent/CZ382196A3/cs unknown
- 1995-06-20 MX MX9700007A patent/MX9700007A/es unknown
- 1995-06-20 CA CA002193859A patent/CA2193859A1/en not_active Abandoned
- 1995-06-20 CN CN95193817A patent/CN1151759A/zh active Pending
- 1995-06-20 NZ NZ287124A patent/NZ287124A/en unknown
- 1995-06-20 WO PCT/IB1995/000497 patent/WO1996000783A1/en not_active Application Discontinuation
- 1995-06-20 JP JP8502979A patent/JPH11505401A/ja active Pending
- 1995-06-20 EP EP95920192A patent/EP0804579A1/en not_active Withdrawn
- 1995-06-20 SK SK1669-96A patent/SK166996A3/sk unknown
- 1995-06-20 US US08/765,469 patent/US6069301A/en not_active Expired - Fee Related
- 1995-06-20 AU AU25735/95A patent/AU696661B2/en not_active Ceased
- 1995-06-20 HU HU9603526A patent/HUT76089A/hu unknown
- 1995-06-20 BR BR9508154A patent/BR9508154A/pt not_active Application Discontinuation
- 1995-06-20 PL PL95318164A patent/PL318164A1/xx unknown
-
1997
- 1997-01-24 BG BG101171A patent/BG101171A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US6069301A (en) | 2000-05-30 |
EP0804579A1 (en) | 1997-11-05 |
CN1151759A (zh) | 1997-06-11 |
JPH11505401A (ja) | 1999-05-21 |
AU696661B2 (en) | 1998-09-17 |
NZ287124A (en) | 1999-04-29 |
CA2193859A1 (en) | 1996-01-11 |
US5686600A (en) | 1997-11-11 |
EE9600192A (et) | 1997-06-16 |
AU2573595A (en) | 1996-01-25 |
CZ382196A3 (cs) | 1998-03-18 |
HUT76089A (en) | 1997-06-30 |
BG101171A (en) | 1997-10-31 |
WO1996000783A1 (en) | 1996-01-11 |
BR9508154A (pt) | 1998-07-14 |
PL318164A1 (en) | 1997-05-26 |
SK166996A3 (en) | 1997-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9700007A (es) | Anticuerpos que fijan las proteinas del intestino de los insectos y su uso. | |
ATE178652T1 (de) | Verbessertes verfahren zur herstellung von endotoxinbindungsproteinen | |
DE60033293D1 (de) | Neue b7-4 moleküle und deren verwendungen | |
AR013422A1 (es) | UN VECTOR DE EXPRESIoN REPLICABLE QUE COMPRENDE UN ÁCIDO NUCLEICO QUE CODIFICA PARA UN POLIPÉPTIDO, UNA CÉLULA HUÉSPED ANIMAL AISLADA INCAPAZ DE CONDUCIR A UN ORGANISMO COMPLETO, UN MICROORGANISMO, UN MÉTODO PARA PRODUCIR UN POLIPEPTIDO DE SEC IN N° 2, UNA PROTEíNA DE FUSIoN, UN ANTICUERPO MONOCLONA | |
ATE270337T1 (de) | Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen | |
RU94045919A (ru) | Антитела, клетки, полипептид, днк векторы, способ получения полипептида, способ получения антитела, фармацевтическая композиция | |
AP9901541A0 (en) | Broad-spectrum delta-endotoxins. | |
NO963371L (no) | Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det | |
AU6063500A (en) | Glycoprotein vi and uses thereof | |
IE820069L (en) | Recombinant dna encoding a polypeptide | |
HK1012841A1 (en) | Pharmaceutical composition for the treatment or prevention of amalignant tumor | |
ATE189478T1 (de) | Für die reinigung bestimmte klonierung von peptiden | |
HUP9800730A2 (hu) | Expressziós rendszer heterológ antigének fúziós proteinként történő expresszáltatására | |
EP1746162A3 (en) | Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell | |
DE68926882D1 (de) | Plasmidvektor mit pectatlyase-signalsequenz | |
DE60035517D1 (de) | Gl50 moleküle, sowie verwendungen derselben | |
ATE79136T1 (de) | Hybrides protein. | |
CA2053911A1 (en) | Recombinant antibody-toxin fusion protein | |
NZ333203A (en) | Tumour antigen proteins, genes thereof, and tumour antigen peptides | |
EP1710299A3 (en) | Secreted proteins and nucleic acids encoding them | |
CA2126182A1 (en) | Humanized antibodies reactive with gpiib/iiia | |
PT625157E (pt) | Epitopes p1a1 e p1a2 da gpiiia da plaqueta sua preparacao e utilizacao | |
DE69329190D1 (de) | Autotaxin : ein das selbständige zellbewegungsvermögen stimulierendes protein nützlich in der krebs-diagnostik und therapie | |
ATE295890T1 (de) | Vektor zur expression von n-terminal verlängerten proteinen in hefezellen | |
CA2218755A1 (en) | Monoclonal antibody to human beta 2 integrin alpha subunit |